Seoul, South Korea

Pil Jong Shim

This inventor holds 2 USPTO granted patents. Top assignee: Dongkook Pharmaceutical Co., Ltd.. Active years: 2000-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pil Jong Shim. Retrieved from https://idiyas.com/inventor/pil-jong-shim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 2000-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Pil Jong Shim

Introduction

Pil Jong Shim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of cognitive disorders. With a total of 2 patents, his work focuses on innovative solutions for dementia and related conditions.

Latest Patents

Among his latest patents, Pil Jong Shim has developed medicines for treating dementia or cognitive disorders, which include asiatic acid derivatives. One of his key inventions is the use of 2-oxoasiatic acid in the treatment of these conditions. Additionally, he has worked on asiatic acid derivatives that feature a modified A-ring, showcasing his commitment to advancing medical science.

Career Highlights

Pil Jong Shim is currently associated with Dongkook Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work has the potential to improve the quality of life for many individuals suffering from cognitive impairments.

Collaborations

He has collaborated with notable colleagues, including Sang Sup Jew and Hyeung Geun Park, to further enhance his research and development efforts.

Conclusion

Pil Jong Shim's contributions to the field of medicine, particularly in the treatment of cognitive disorders, highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to inspire advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…